Alexion Pharmaceuticals Q4 Adj. EPS $2.71 Beats $2.58 Estimate, Sales $1.384B Beat $1.3B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.58 by 5.04 percent. This is a 26.64 percent increase over earnings of $2.14 per share

Benzinga · 01/30/2020 11:30

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.58 by 5.04 percent. This is a 26.64 percent increase over earnings of $2.14 per share from the same period last year. The company reported quarterly sales of $1.384 billion which beat the analyst consensus estimate of $1.3 billion by 6.46 percent. This is a 22.59 percent increase over sales of $1.129 billion the same period last year.